tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:TG1N Stock Latest News

Armata price target raised to $15 from $9 at H.C. Wainwright
The FlyArmata price target raised to $15 from $9 at H.C. Wainwright
3d ago
ARMP
Armata Gains QIDP Status for AP-SA02 Bacteremia Therapy
PremiumCompany Announcements
Armata Gains QIDP Status for AP-SA02 Bacteremia Therapy
3d ago
8K
ARMP
Armata Pharmaceuticals receives FDA QIDP designation for AP-SA02
PremiumThe Fly
Armata Pharmaceuticals receives FDA QIDP designation for AP-SA02
3d ago
ARMP
Armata Extends Innoviva Credit, Warrants and Voting Pact
PremiumCompany Announcements
Armata Extends Innoviva Credit, Warrants and Voting Pact
1M ago
8K
ARMP
Armata Pharmaceuticals: FDA-Endorsed Phase 3 Path and Potential QIDP Upside Support Buy Rating on AP-SA02
PremiumRatings
Armata Pharmaceuticals: FDA-Endorsed Phase 3 Path and Potential QIDP Upside Support Buy Rating on AP-SA02
1M ago
ARMP
Armata Wins FDA Support to Advance Bacteriophage to Phase 3
PremiumCompany AnnouncementsArmata Wins FDA Support to Advance Bacteriophage to Phase 3
1M ago
8K
ARMP
Armata Pharmaceuticals announces End-of-Phase 2 meeting with FDA
Premium
The Fly
Armata Pharmaceuticals announces End-of-Phase 2 meeting with FDA
1M ago
ARMP
Armata Pharmaceuticals initiated with a Buy at JonesResearch
Premium
The Fly
Armata Pharmaceuticals initiated with a Buy at JonesResearch
2M ago
ARMP
Armata Pharmaceuticals Enters Capital Sales Agreement
PremiumCompany Announcements
Armata Pharmaceuticals Enters Capital Sales Agreement
3M ago
8K
ARMP
Armata Pharmaceuticals: Strategic Advancements and Clinical Progress Drive Buy Rating
PremiumRatings
Armata Pharmaceuticals: Strategic Advancements and Clinical Progress Drive Buy Rating
4M ago
ARMP
Armata Pharmaceuticals reports Q3 EPS (74c) vs. (15c) last year
PremiumThe Fly
Armata Pharmaceuticals reports Q3 EPS (74c) vs. (15c) last year
4M ago
ARMP
Armata Pharmaceuticals: Strategic Advancements and Operational Milestones Justify Buy Rating
PremiumRatings
Armata Pharmaceuticals: Strategic Advancements and Operational Milestones Justify Buy Rating
4M ago
ARMP
Armata Pharmaceuticals trading resumes
PremiumThe FlyArmata Pharmaceuticals trading resumes
4M ago
ARMP
Armata Pharmaceuticals trading halted, volatility trading pause
Premium
The Fly
Armata Pharmaceuticals trading halted, volatility trading pause
4M ago
ARMP
Armata announces comissioning of cGMP manufacturing facility in Los Angeles
Premium
The Fly
Armata announces comissioning of cGMP manufacturing facility in Los Angeles
4M ago
ARMP
ARMP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ARMP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
ARMP
Armata Pharmaceuticals Reports Positive Phase 2a Study Results
PremiumCompany Announcements
Armata Pharmaceuticals Reports Positive Phase 2a Study Results
4M ago
8K
ARMP
Promising Efficacy of Armata Pharmaceuticals’ AP-SA02 in Phase 2a Study Boosts Buy Rating
PremiumRatings
Promising Efficacy of Armata Pharmaceuticals’ AP-SA02 in Phase 2a Study Boosts Buy Rating
4M ago
ARMP
Armata data support advancing AP-SA02 to Phase 3, says H.C. Wainwright
PremiumThe Fly
Armata data support advancing AP-SA02 to Phase 3, says H.C. Wainwright
4M ago
ARMP
Armata Pharmaceuticals up 19% after reporting results of diSArm study
PremiumThe FlyArmata Pharmaceuticals up 19% after reporting results of diSArm study
4M ago
ARMP
Armata Pharmaceuticals trading resumes
Premium
The Fly
Armata Pharmaceuticals trading resumes
4M ago
ARMP
Armata says diSArm study confirms efficacy of intravenous phage therapy for SAB
Premium
The Fly
Armata says diSArm study confirms efficacy of intravenous phage therapy for SAB
4M ago
ARMP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >